Pradaxa Maker Denied JMOL, New Trial In $1.7M Bleeding Injury Trial

Mealey's (May 20, 2019, 8:48 AM EDT) -- HUNTINGDON, W.Va. — A West Virginia federal judge on May 15 denied judgment as a matter of law (JMOL) or a new trial to drug maker Boehringer Ingelheim Pharmaceuticals Inc. in...
To view the full article, register now.